Location History:
- Indianapolis, IN (US) (2000)
- Rockville, MD (US) (1997 - 2005)
Company Filing History:
Years Active: 1997-2005
Title: The Innovations of Bin Zeng
Introduction
Bin Zeng is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of genetics, particularly in relation to the BRCA1 gene. With a total of 5 patents, his work has implications for cancer susceptibility and gene therapy.
Latest Patents
Zeng's latest patents focus on the coding sequences of the human BRCA1 gene. His inventions include isolated coding sequences and the protein sequences they code for. Specifically, he has directed his research towards three coding sequences of the BRCA1 gene, identified as BRCA1.sup.(omi1), BRCA1.sup.(omi2), and BRCA1.sup.(omi3). These sequences, along with their frequencies of occurrence, are provided alongside the corresponding protein sequences. Additionally, Zeng has developed methods for determining the consensus sequence for any gene and identifying individuals with an increased genetic susceptibility to breast or ovarian cancer due to inherited mutations in their BRCA1 gene. His inventions also encompass methods for performing gene therapy and protein therapy using the isolated BRCA1 coding sequences and their functional equivalents.
Career Highlights
Throughout his career, Bin Zeng has worked with several companies, including Oncormed, Inc. and Gene Logic, Inc. His expertise in genetics and innovation has positioned him as a key figure in the development of genetic therapies.
Collaborations
Zeng has collaborated with notable coworkers such as Patricia D Murphy and Sheri J Olson, contributing to advancements in genetic research and therapy.
Conclusion
Bin Zeng's contributions to the field of genetics, particularly through his patents related to the BRCA1 gene, highlight his role as an influential inventor. His work continues to impact the understanding and treatment of genetic conditions.